Streetbeat News

Equity Actions

SPCE

Virgin Galactic's board has approved a 1-for-20 reverse stock split, effective June 14, 2024, after market close. Split-adjusted trading will begin on June 17, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:32 pm

ARES

Ares Management has announced the launch of a public offering of 2.65 million shares of Class A common stock, with an option for underwriters to purchase an additional 397,500 shares. The proceeds will be used for general corporate purposes, including debt repayment, strategic acquisitions, and growth initiatives.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:27 pm

AVGO

Broadcom shares are trading higher after the company reported better-than-expected Q2 financial results, issued strong revenue guidance, and announced a 10-for-1 forward split.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:18 pm

AVGO

Broadcom (AVGO) has announced a 10-for-1 forward stock split, which will take effect on July 15. This move is expected to make the stock more accessible to a broader range of investors.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:18 pm

CNTB

Connect Biopharma has appointed Barry Quart as CEO and Director, David Szekeres as President, and Kleanthis Xanthopoulos as the new Chair. The previous CEO, Zheng Wei, and Chair, Wubin (Bill) Pan, will remain on the Board and serve as advisors during the transition.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:17 pm

WRB

W. R. Berkley Corporation has approved a 3-for-2 common stock split.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:17 pm

NICK

On June 6, 2024, Nicholas Financial's CFO Irina Nashtatik resigned. Charles Krebs will be appointed as the new CFO on June 19, 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:14 pm

RARE

Ultragenyx shares are trading lower following the announcement of a proposed public offering of common stock and pre-funded warrants.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:09 pm

RARE

Ultragenyx Pharmaceutical has announced a $350 million public offering of common stock and pre-funded warrants.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:07 pm

JILL

J.Jill has announced a proposed offering of 2 million shares of its common stock, with 1 million shares offered by the company and 1 million shares by an affiliate of TowerBrook Capital Partners L.P. The proceeds from J.Jill's share sale will be used for debt repayment and general corporate purposes, while the company will not receive any proceeds from the shares sold by the affiliate.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:06 pm